 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
first...this today (then see following news release) ...HDRN trades at around .75/.88 on otc bb...yahoo profile has 5.1m shares outstanding...remember, the story today is suggesting $3.2 BILLION to be spent on this stuff: (COMTEX) A: Panel will call for $3.2 billion in biological defense A: Panel will call for $3.2 billion in biological defense WASHINGTON, Sept. 5 (UPI) - A panel of senior advisors to the Defense Department is urging the Pentagon to create a massive new $3.2 billion program to protect the country from terrorists armed, not with bombs, but with engineered diseases that could kill thousands or even millions of people before the man-made outbreaks are detected. The Defense Science Board will recommend in a report to be made public later this month that the Defense Department create a new organization to oversee the development of a data base of biological weapons, a computer chip to automatically diagnose the diseases in patients, and a computer network that will rapidly warn health care centers about man-made outbreaks. United Press International obtained a draft copy of the report, entitled "Task Force on Defense Against Biological Weapons." The science board says the United States is wholly unprepared for an attack of any magnitude, asserting a wave of 100 to 1,000 cases of one of these diseases in a single city would collapse the health care system. The board warns there are massive shortfalls in medical supplies to address a "significant bio incident" and no plans to address the shortage. The science board paints a grim picture of the brutal effectiveness of biological warfare: An attack on a city with 100 kilograms of bioagent would kill one to three million people, twice the number of fatalities that would result from a one megaton nuclear weapon. Moreover, because of the commercial nature of the ingredients needed to manufacture viruses and pathogens, biological weapons are harder for governments and monitoring regimes to track and control than nuclear weapons development. The collapse of the Soviet Union and its robust germ warfare program makes the possibility of such weapons getting into the hands of terrorists or criminals even more likely. At one former biological warfare center in Almaty, Kazakhstan, there are 900 strains of the plague, 300 of anthrax, 200 of tularemia and 200 of cholera. The first step recommended by the board is for the Defense Department to create a "Bio-Print" database that would create "signatures" of the to 50 bioagents that cause human disease. It says an "urgent priority" would be acquiring and profiling former Soviet strains and agents, which would not only yield medicines and vaccines against them but also help track leakage of the diseases into "states of concern" like Iraq and terrorist groups. At the same time, it would profile the signatures of organisms used in the private sector for legitimate purposes. This project would cost about $675 million over five years to map about 1,350 genomes, according to the report. Only 100 microbial genomes have been sequenced to date, according to the report which warns of a "massive capacity gap in public and private sector." The next step would be to create the diagnostic "Zebra Chip" - a reference that compares discerning a zebra from a pack of horses to discerning a bioagent from a multitude of natural human infections. The miniaturized zebra computer chip would provide immediate diagnoses of diseases documented in the Bio-Print database, flagging manmade or unusual diseases to health care workers even before there are symptoms. It would be non-intrusive and disposable, working with a sample collected from a patient during a routine clinical screening. The chips would be introduced in the DOD health care system which serves 4.4 million people, and eventually transferred to the civilian health care system. The same computer chips could also be used to screen immigrants and visitors to the country to detect whether they have been handling or exposed to biological weapons, according to the panel's report. The science board estimates these chips could be produced for between $1 and $2, with 12 million produced the first year for DOD patients. If the "front line" zebra chip detected bioagents, the Defense Department would then deploy more sophisticated forensic zebra chips designed to probe for the specific agent in question. The Defense Science Board estimates those chips would cost around $52 million. Once a biological agent has been confirmed, the information would be broadcast on the Biological Warning and Communication System (BWACS), which would warn all DOD health care organizations, military bases, the Reserves and the Center for Disease Control and other civilian health organizations. With a staff of 150 and an initial investment of $300 million, the BWACS would gobble the lion's share of funding, requiring $1.5 billion over five years. At the same time, the science board is recommending the Pentagon invest heavily in research and development for bioagents drugs and vaccines, and work with the Food and Drug Administration to accelerate the review process. It also recommends the Pentagon fund a $50 million to $100 million manufacturing facility for vaccines or after-exposure drugs in order to speed production. Overseeing all this development would be a new organization called the Joint BioDefense Organization. The JBDO would direct the military response to a bioagent outbreak and would coordinate efforts with the civilian sector and media, and would report directly to the president and the defense secretary through the chairman of the Joint Chiefs of Staff. The study was chaired by George Poste, chief executive officer of Health Technology Networks, a consulting group that specializes in the impact of genetics, computing and other advanced technologies on healthcare research and development. He was previously the president of research and development at SmithKline Beecham and was involved in the Human Genome Project. (c) 2000 UPI All rights reserved. -0- Copyright 2000 by United Press International. then this back in May...add them up and what do you get? maybe some recognition soon for hdrn, more contracts like this one and maybe a higher stock price down the road... (PR NEWSWIRE) HADRON Subsidiary Awarded $3.3 Million Biodefense Contract by D HADRON Subsidiary Awarded $3.3 Million Biodefense Contract by DARPA ALEXANDRIA, Va., May 4 /PRNewswire/ -- Hadron, Inc. (OTC Bulletin Board: HDRN) today announced that one of its wholly-owned subsidiaries has been awarded a $3.3 million, one-year contract by the Defense Advanced Research Projects Agency (DARPA). Hadron's subsidiaries, Avenue Technologies, Inc. and Advanced Biosystems, Inc., will perform the biodefense research programs under this contract. The scientific and medical research will consist of several related programs regarding the development of rapid-acting broad-spectrum protection against biological threat agents. Southern Research Institute, a well known research organization based in Birmingham, Alabama, is a subcontractor on this program. "We are pleased to be working with DARPA to provide proof of concept of certain innovative medical concepts regarding protection against biological threat agents," said Dr. Ken Alibek, Hadron's Chief Scientist and President of Advanced Biosystems. "There are many novel approaches to biological weapons defense that I believe may provide superior protection than those methods currently in use," Dr. Alibek continued. "We hope this program is just the beginning of new, innovative research, funded by government agencies and the private sector, to develop new prophylactic means and treatments for a broad spectrum of infectious diseases," he concluded. Hadron specializes in developing innovative technical solutions for the intelligence community, analyzing and supporting defense systems (including intelligent weapons systems and biological weapons defense), and supporting complex computer systems. Hadron can be found on the Internet at hadron.com . Except for the historical information contained herein, this press release contains forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, that involve a number of risks and uncertainties. These forward-looking statements may be identified by reference to a future period by use of forward-looking terminology such as "anticipate", "expect", "could", "may" and other words of similar nature. There are certain important factors and risks that could cause results to differ materially from those anticipated by the statements contained herein. Such factors and risks include business conditions and growth in the information services, engineering services, software development and government contracting arenas and in the economy in general. Competitive factors include the pressures toward consolidation of small government contracts into larger contracts awarded to major, multi-national corporations; and the Company's ability to continue to recruit and retain highly skilled technical, managerial and sales/marketing personnel. Other risks may be detailed from time to time in the Company's filings with the Securities and Exchange Commission. Hadron undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. SOURCE HADRON, Inc. -0- 05/04/2000 /CONTACT: Amber Gordon, Executive Vice President, of HADRON, Inc., 703-329-9400, ext. 311, or agordon@hadron.com/ /Web site: hadron.com (HDRN) CO: HADRON, Inc.; Avenue Technologies, Inc.; Advanced Biosystems, Inc.; Southern Research Institute ST: Virginia IN: BIO CPR ARO SU: CON *** end of story *** | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |